Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.851 | 0.040 | 6 | 30945681 | intron variant | G/A | snv | 9.3E-02 |
|
Mental Disorders | 0.800 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.120 | 6 | 30953113 | missense variant | G/A | snv | 0.29 | 0.26 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2007 | 2009 | ||||||
|
1.000 | 0.040 | 6 | 30931418 | 3 prime UTR variant | G/A;C;T | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 30931418 | 3 prime UTR variant | G/A;C;T | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 30937536 | intron variant | A/G | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 30937536 | intron variant | A/G | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 30939558 | intron variant | T/C | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 6 | 30953587 | 3 prime UTR variant | C/T | snv | 0.21 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 30953587 | 3 prime UTR variant | C/T | snv | 0.21 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 30953587 | 3 prime UTR variant | C/T | snv | 0.21 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 30953587 | 3 prime UTR variant | C/T | snv | 0.21 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 30936937 | intron variant | G/A | snv | 0.18 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
1.000 | 6 | 30936937 | intron variant | G/A | snv | 0.18 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
1.000 | 6 | 30936937 | intron variant | G/A | snv | 0.18 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
1.000 | 6 | 30936937 | intron variant | G/A | snv | 0.18 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
1.000 | 0.080 | 6 | 30932317 | intron variant | T/C | snv | 0.74 |
|
Digestive System Diseases; Infections | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.200 | 6 | 30937536 | intron variant | A/G | snv | 0.42 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.200 | 6 | 30937536 | intron variant | A/G | snv | 0.42 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.790 | 0.360 | 6 | 30952347 | missense variant | G/A | snv | 8.0E-02 | 9.3E-02 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | ||||||
|
0.790 | 0.360 | 6 | 30952347 | missense variant | G/A | snv | 8.0E-02 | 9.3E-02 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.790 | 0.360 | 6 | 30952347 | missense variant | G/A | snv | 8.0E-02 | 9.3E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.790 | 0.360 | 6 | 30952347 | missense variant | G/A | snv | 8.0E-02 | 9.3E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.790 | 0.360 | 6 | 30952347 | missense variant | G/A | snv | 8.0E-02 | 9.3E-02 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.790 | 0.360 | 6 | 30952347 | missense variant | G/A | snv | 8.0E-02 | 9.3E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.790 | 0.360 | 6 | 30952347 | missense variant | G/A | snv | 8.0E-02 | 9.3E-02 |
|
Neoplasms; Immune System Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 |